These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10178666)

  • 1. Valuation of EuroQOL (EQ-5D) health states in an adult US sample.
    Johnson JA; Coons SJ; Ergo A; Szava-Kovats G
    Pharmacoeconomics; 1998 Apr; 13(4):421-33. PubMed ID: 10178666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single European currency for EQ-5D health states. Results from a six-country study.
    Greiner W; Weijnen T; Nieuwenhuizen M; Oppe S; Badia X; Busschbach J; Buxton M; Dolan P; Kind P; Krabbe P; Ohinmaa A; Parkin D; Roset M; Sintonen H; Tsuchiya A; de Charro F
    Eur J Health Econ; 2003 Sep; 4(3):222-31. PubMed ID: 15609189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient versus general population health state valuations: a case study of non-specific low back pain.
    van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
    Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social valuation of EQ-5D health states: the Chilean case.
    Zarate V; Kind P; Valenzuela P; Vignau A; Olivares-Tirado P; Munoz A
    Value Health; 2011 Dec; 14(8):1135-41. PubMed ID: 22152184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.
    Johnson JA; Ohinmaa A; Murti B; Sintonen H; Coons SJ
    Med Decis Making; 2000; 20(3):281-9. PubMed ID: 10929850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.
    Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Farragher TM; Verstappen SM; Hassell A; Symmons DP
    Value Health; 2009 Sep; 12(6):1026-34. PubMed ID: 19473335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
    Shaw JW; Johnson JA; Coons SJ
    Med Care; 2005 Mar; 43(3):203-20. PubMed ID: 15725977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.
    Xie F; Gaebel K; Perampaladas K; Doble B; Pullenayegum E
    Med Decis Making; 2014 Jan; 34(1):8-20. PubMed ID: 23525701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How is the most severe health state being valued by the general population?
    Gandhi M; Thumboo J; Wee HL; Luo N; Cheung YB
    Health Qual Life Outcomes; 2014 Oct; 12():161. PubMed ID: 25344269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
    Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
    Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese time trade-off values for EQ-5D health states.
    Liu GG; Wu H; Li M; Gao C; Luo N
    Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.